Surveillance of chronic haemodialysis-associated infections in southern Israel

Clinical Microbiology and Infection

Volumn 11, Issue 7, 2005, Pages 547-552

  Gilad, J ^a   Eskira, S ^a   Schlaeffer, F ^a   Vorobiov, M ^a   Marcovici, A ^a   Tovbin, D ^a   Zlotnik, M ^a   Borer, A ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antibiotic resistance; Catheter; Chronic; Haemodialysis; Infection; Resistance

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; BACTERIAL STRAIN; BLOOD VESSEL CATHETERIZATION; CATHETER INFECTION; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEALTH SURVEY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; ISRAEL; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STANDARDIZATION; TREATMENT INDICATION; VASCULAR ACCESS;

FISTULA;

EID: 21244488213     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01168.x     Document Type: Article

References (20)

1. Horl WH. Neutrophil function and infections in uremia. Am J Kidney Dis 1999; 33: xlv-xlvii.
2. Fridkin S. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32: 108-115.
3. Montecalvo MA, Shay DK, Patel P et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996; 156: 1458-1462.
4. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002; 30: 288-295.
5. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50: 1-63.
6. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis: a multi-center prospective survey. Nephron 1993; 64: 95-100.
7. Bonomo RA, Rice D, Whalen C, Linn D, Eckstein E, Shlaes DM. Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 1997; 18: 757-761.
8. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBAC-DIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-876.
9. Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild JP. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Cont Hosp Epidemiol 2000; 21: 200-203.
10. Stevenson KB, Hannah EL, Lowder CA et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002; 39: 549-555.
11. Anonymous. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37(suppl 1): S137-S181.
12. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 2004; 44(suppl 3): 22-26.
13. Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004; 17: 310-319.
14. Shay DK, Maloney SA, Montecalvo M et al. Epidemiology and mortality risk of vancomycin resistant enterococcal bloodstream infections. J Infect Dis 1995; 172: 993-1000.
15. Stroud L, Edwards J, Danzig L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal blood stream infections. Infect Cant Hosp Epidemiol 1996; 17: 576-580.
16. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. MMWR 1999; 48: 1165-1167.
17. Green K, Schulman G, Haas DW, Schaffner W, D'Agata EM. Vancomycin prescribing practices in hospitalized chronic hemodialysis patients. Am J Kidney Dis 2000; 35: 64-68.
18. Fogel MA, Nussbaum PB, Feintzeig ID, Hunt WA, Gavin JR, Kim RC. Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. Am J Kidney Dis 1998; 32: 401-409.
19. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 2003; 16: 30-37.
20. Shmuely H, Pitlik S, Yahav J, Samra Z, Leibovici L. Seven-year study of bacteremia in hospitalized patients on chronic hemodialysis in a single tertiary hospital. Renal Failure 2003; 25: 579-588.